Abiopharma

🔍 SHEA JOHN CHRISTOPHER (Executive)

Company: HEALTHCARE SERVICES GROUP INC (HCSG)

Report Date: 2026-02-24

Detailed Transactions and Holdings:

• Acquired 4,416 shares of Common Stock (Direct)
  Date: 2026-02-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 33,708.00 | transaction_form_type: 4
• Sold 1,874 shares of Common Stock at $21.4 per share (Direct)
  Date: 2026-02-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 31,834.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 12,618 shares of Common Stock (Direct)
  Date: 2026-02-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 44,452.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 5,353 shares of Common Stock at $21.4 per share (Direct)
  Date: 2026-02-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 39,099.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,416 shares of Restricted Stock Units (Derivative)
  Date: 2026-02-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,830.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4

Footnotes:

• F1: Represents shares withheld to pay taxes.
• F2: Represents common stock earned and delivered on a performance stock unit award previously granted in February 2023, based on the satisfaction of certain financial performance criteria for the period ended December 31, 2025. The Company's Nominating, Compensation and Stock Option Committee certified the level of performance-goal attainment on February 24, 2026 and the shares vested upon certification.
• F3: Shares issued at the conversion rate of 1-for-1.
• F4: These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the February 24, 2023 grant date.